Xylometazoline Hydrochloride

Especificaciones

1218-35-5Número CAS

214-936-4Número CE

2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole;hydrochlorideNombre IUPAC

C16H25ClN2Fórmula química

280.83 g/molPeso molecular

Xylometazoline hydrochloride; 1218-35-5; Xylometazoline HCl; Neo-Synephrine II; Otrivin hydrochloride; DTXSID3045223; NSC-757378; DTXCID1025223; X5S84033NZ; Xylometazoline hydrochloride (USP); 2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline monohydrochloride; 1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, monohydrochloride; 1H-Imidazole, 2-((4-(1,1-dimethylethyl)-2,6-dimethylphenyl)methyl)-4,5-dihydro-, monohydrochloride; Sinosil; Xylomet hcl; Nazo-mist; Otrivine hay fever for; RefChem:58082; Metarivin Soln. 0.1%; Sinosil Nasal Decongestant; 214-936-4; Otrivine; Xylometazoline (hydrochloride); MFCD00238707; 2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline hydrochloride; 2-(4-(tert-butyl)-2,6-dimethylbenzyl)-4,5-dihydro-1H-imidazole hydrochloride; Rhinactin; 1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, hydrochloride (1:1); MLS000069695; SMR000058526; 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole hydrochloride; SR-01000000230; NCGC00016101-02; CAS-1218-35-5; Prestwick_574; Opera_ID_1744; Neo-Synephrine II (TN); SCHEMBL41837; MLS001076518; SPECTRUM1500614; orb1226773; orb1310993; orb3024938; Xylometazoline hydrochloride CRS; CHEMBL1256400; HY-B0475R; Oxymetazoline EP Impurity B HCl; XYLOMETAZOLINEHYDROCHLORIDE; REGID_for_CID_5282386; HMS1568N07; HMS1921K09; HMS5081N05; Pharmakon1600-01500614; HY-B0475; Tox21_110305; Tox21_501269; CCG-39900; EBC-04431; MSK161560; NSC757378; s2576; AKOS015895456; Tox21_110305_1; AC-8301; FX28743; KS-5144; LP01269; NCGC00016101-10; NCGC00094506-01; NCGC00094506-02; NCGC00094506-03; NCGC00094506-04; NCGC00094506-05; NCGC00261954-01; XYLOMETAZOLINE HYDROCHLORIDE [MI]; Xylometazoline (hydrochloride) (Standard); XYLOMETAZOLINE HYDROCHLORIDE [MART.]; XYLOMETAZOLINE HYDROCHLORIDE [VANDF]; EU-0101269; NS00081176; SW196748-3; T0042; X0063; XYLOMETAZOLINE HYDROCHLORIDE [USP-RS]; XYLOMETAZOLINE HYDROCHLORIDE [WHO-DD]; D00757; X 6000; Xylometazoline Hcl; Oxymetazoline EP Impurity B; Xylometazoline hydrochloride, analytical standard; F861786; XYLOMETAZOLINE HYDROCHLORIDE [EP MONOGRAPH]; SR-01000000230-2; SR-01000000230-7; XYLOMETAZOLINE HYDROCHLORIDE [USP MONOGRAPH]; Q27293585; Z2242061948; 2-(4-tert-butyl-2,6-dimethylbenzyl)-4,5-dihydro-1h-imidazole hydrochloride; Xylometazoline Hydrochloride Working Standard (Secondary Reference Standard); Xylometazoline hydrochloride, British Pharmacopoeia (BP) Reference Standard; Xylometazoline hydrochloride, European Pharmacopoeia (EP) Reference Standard; 2-[(4-tert-butyl-2,6-dimethyl-phenyl)methyl]-4,5-dihydro-1H-imidazol-1-ium;chloride; Xylometazoline hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; Xylometazoline hydrochloride, United States Pharmacopeia (USP) Reference Standard; 2-[(4-tert-Butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole--hydrogen chloride (1/1); 2-[[4-(1,1-Dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-1H-imidazole hydrochlorideSinónimos